Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Impact of Macrolides on Critically Ill Patients with Community-acquired Pneumonia

FY 2022-23

Summary
Pneumonia is a common lung infection that can cause severe illness and inflammation. Pneumonia is treated with antibiotics, and one of the antibiotic groups used to treat it are called “macrolides.” Macrolides have infection-fighting properties, but can also affect inflammation in the body. Some people with pneumonia need breathing tubes and intensive care to stay alive. We want to study if macrolides can reduce deaths in people with severe pneumonia. We also want to study if they can improve other important outcomes like the length of time with a breathing tube and stay in intensive care. We will study these questions using two projects: 1. The first study will compare one group of patients who got macrolides to another group who did not get macrolides. This will help us evaluate which group of patients fared better and by how much, and help us to answer if future patients in similar circumstances can benefit from macrolides. 2. The second study involves searching for existing studies that were done to answer these questions and combining their results in a “study of studies.” This is done to get a more definitive answer with more data in different settings. We plan on judging each study's quality and summarizing the findings of each study. We also plan on mathematically combining the studies' results using statistics to give us numerical estimates for the impact of macrolide medications. The findings of these studies would help guide best practices for severely ill patients with pneumonia. These studies are often used to update best-practice treatment recommendations for healthcare professionals in local communities, across Canada, and worldwide. The aim would be to help patients in the future get the best treatment available for severe pneumonia.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486097
Name
Qaddoura Amro
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Impact of Macrolides on Critically Ill Patients with Community-acquired Pneumonia
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Critical Illness; Macrolide; Pneumonia
Abstract
Pneumonia is a common lung infection that can cause severe illness and inflammation. Pneumonia is treated with antibiotics, and one of the antibiotic groups used to treat it are called “macrolides.” Macrolides have infection-fighting properties, but can also affect inflammation in the body. Some people with pneumonia need breathing tubes and intensive care to stay alive. We want to study if macrolides can reduce deaths in people with severe pneumonia. We also want to study if they can improve other important outcomes like the length of time with a breathing tube and stay in intensive care. We will study these questions using two projects: 1. The first study will compare one group of patients who got macrolides to another group who did not get macrolides. This will help us evaluate which group of patients fared better and by how much, and help us to answer if future patients in similar circumstances can benefit from macrolides. 2. The second study involves searching for existing studies that were done to answer these questions and combining their results in a “study of studies.” This is done to get a more definitive answer with more data in different settings. We plan on judging each study's quality and summarizing the findings of each study. We also plan on mathematically combining the studies' results using statistics to give us numerical estimates for the impact of macrolide medications. The findings of these studies would help guide best practices for severely ill patients with pneumonia. These studies are often used to update best-practice treatment recommendations for healthcare professionals in local communities, across Canada, and worldwide. The aim would be to help patients in the future get the best treatment available for severe pneumonia.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Qaddoura, Amro
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~